Prof. Armin Gerger provides the highlights on cancers of the liver, small intestine and pancreas tract from ESMO 2016
Cancer of the Liver, Small Intestine and Pancreas tract by Prof. Armin Gerger
Prof. Armin Gerger provides the highlights on cancers of the liver, small intestine and pancreas tract from ESMO 2016
Cancer of the Liver, Small Intestine and Pancreas tract by Prof. Armin Gerger
Since 2012 Dr Armin Gerger is professor at the Medial University in Graz, Austria. He works as a clinical oncologist and coordinates the Subcentre for Gastrointestinal Neoplasia at the Comprehensive Cancer Centre, Graz. He leads the Pharmacogenetics Research Unit, at the Division of Clinical Oncology of the Medical University of Graz, and the Area “Cancer” of the Centre for Biomarker Research in Medicine (CBmed). Dr Gerger’s research focuses on prognostic and predictive genetic biomarkers in gastrointestinal cancer, which he developed further as a research fellow at the Norris Comprehensive Cancer Centre of the University of Southern California. Dr Gerger’s research activity is mirrored in several papers in high-ranked scientific journals and significant extramural funding.
Integrating multimodal approaches with multidisciplinary care
Exploring the impact of liquid biopsy in advanced breast cancer
Exploring the impact of molecular subtypes
Expert insights on systemic, loco-regional, and multimodal therapies
Two emerging and two established targets